Baseline ctDNA analyzed for thrombotic risk in locally advanced rectal cancer
Skip to content
The CRC Digest
Baseline ctDNA analyzed for thrombotic risk in locally advanced rectal cancer
Plasma ctDNA was analyzed by droplet digital PCR for tumor-specific mutations including KRAS, NRAS, BRAF, and PIK3CA to explore association with VTE occurrence. (Cancer Treat Res Commun)
This content is informational only and